EcoDrugPlus

Ensembl ID : ENSAPOG00000022597
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSAPOG00000008196
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSAPOG00000003737
Gene Symbol: -
Cross references: -
256 Possible Orthologues:

Ensembl ID : ENSAPOG00000004012
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSAPOG00000002323
Gene Symbol: -
Cross references: -
228 Possible Orthologues:

Ensembl ID : ENSAPOG00000016278
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSAPOG00000003402
Gene Symbol: -
Cross references: -
236 Possible Orthologues:

Ensembl ID : ENSAPOG00000004493
Gene Symbol: -
Cross references: -
403 Possible Orthologues:

Ensembl ID : ENSAPOG00000018059
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSAPOG00000003012
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSAPOG00000015444
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSAPOG00000015310
Gene Symbol: -
Cross references: -
275 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).